| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
3 companies
Margaret Dugan is Director at ONC and has filed Form 4s across 3 companies. Margaret Dugan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $26.7M at current prices.
Historically, Margaret Dugan's trades have earned a below-average insider score of 30/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -14.0%.
The biggest single holding is ONC (~$26.0M) as Director. The ONC filings lean toward selling, a net 212 shares.
Margaret Dugan has 16 Form 4 filings on record from February 2022 to September 2026, across 3 companies: Chief Medical Officer at Whitehawk Therapeutics (WHWK), 2025–2026; Director at BeOne Medicines (ONC), 2022–2026; Chief Medical Officer at Schrodinger (SDGR), 2023–2025.
The 24 reported transactions were 13 option or other derivative awards, 8 stock awards and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $122K.
The largest open-market sale was 212 shares of ONC at an average $309.60 on May 22, 2026, about $66K.
2 of the 3 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | ONC Beone Medicines AG | Director | Sell | 212 | $309.60 | $65,635.56 | -100% | +19.0% | - | |
| Oct 16, 2025 | SDGR Schrodinger, Inc. | Chief Medical Officer | Sell10b5-1 | 1,395 | $21.07 | $29,387.07 | -5.4% | -9.7% | +11.3% | |
| Oct 15, 2024 | SDGR Schrodinger, Inc. | Chief Medical Officer | Sell10b5-1 | 1,531 | $17.78 | $27,225.77 | -10.2% | +10.3% | +16.8% |